Immuron Plans Phase 2 Trial for IMM-529 following FDA review
September 05, 2024 11:54 ET
|
Immuron Limited
Key Points Immuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI)Previous clinical trial data on...
Retrieve Medical, Inc. and OnPoint Healthcare Partners, Inc., Announce Revolutionary Integration Partnership
August 01, 2024 13:35 ET
|
Retrieve Medical, Inc.
BEDMINSTER, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical, Inc. (retrievemedical.com) today announced a technology partnership with OnPoint Healthcare Partners, Inc....
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
April 19, 2024 13:21 ET
|
Retrieve Medical, Inc.
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software
March 22, 2024 08:00 ET
|
Retrieve Medical, Inc.
RETRIEVE MEDICAL HOLDINGS, INC. (RMHI) ANNOUNCES STUDY UPDATE RESULTS UTILIZING RETRIEVE DxTM SOFTWARE
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
February 26, 2024 09:00 ET
|
Retrieve Medical, Inc.
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
Retrieve Medical, Inc. Announces Groundbreaking Patent for Enhancing Electronic Health Records
February 07, 2024 11:32 ET
|
Retrieve Medical, Inc.
Retrieve Medical, Inc. Announces Groundbreaking Patent for Enhancing Electronic Health Records
Microbiome Therapeutics Market Size to Hit $813.38 Million, Globally, by 2030 - Exclusive Report by The Insight Partners
November 10, 2023 05:43 ET
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbiome therapeutics, also referred to as microbiome-based therapies or interventions, are medical procedures that try to use the human microbiome's...
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
September 05, 2023 07:59 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has...
The Importance of Accurate Coding and Documentation in Value-Based Care
July 25, 2023 09:00 ET
|
CHESS Health Solutions
Winston-Salem, NC, July 25, 2023 (GLOBE NEWSWIRE) -- Much has been written about the gaming of risk coding to drive additional revenue, particularly in the Medicare Advantage (MA) program. From a...
AHIMA Microcredentials Empower Health Information Professionals to Thrive in a Skills-Based Job Market
July 20, 2023 07:11 ET
|
American Health Information Management Association (AHIMA)
CHICAGO, July 20, 2023 (GLOBE NEWSWIRE) -- The American Health Information Management Association (AHIMA) is proud to announce the launch of six innovative microcredentials specifically designed for...